ESPO
Sponsors
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions
Chronic Kidney DiseasesNon-Dialysis-Dependent Chronic Kidney Disease
Phase 3
Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis
CompletedNCT03902691
Start: 2019-05-15End: 2022-05-30Updated: 2023-03-09
Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD
NCT03903809
Start: 2019-06-20End: 2022-12-31Updated: 2022-09-01